• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征:患者注册中心、研究数据库和生物库国家会议。

Down syndrome: national conference on patient registries, research databases, and biobanks.

机构信息

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892-7510, USA.

出版信息

Mol Genet Metab. 2011 Sep-Oct;104(1-2):13-22. doi: 10.1016/j.ymgme.2011.07.005. Epub 2011 Jul 13.

DOI:10.1016/j.ymgme.2011.07.005
PMID:21835664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3171614/
Abstract

A December 2010 meeting, "Down Syndrome: National Conference on Patient Registries, Research Databases, and Biobanks," was jointly sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH) in Bethesda, MD, and the Global Down Syndrome Foundation (GDSF)/Linda Crnic Institute for Down Syndrome based in Denver, CO. Approximately 70 attendees and organizers from various advocacy groups, federal agencies (Centers for Disease Control and Prevention, and various NIH Institutes, Centers, and Offices), members of industry, clinicians, and researchers from various academic institutions were greeted by Drs. Yvonne Maddox, Deputy Director of NICHD, and Edward McCabe, Executive Director of the Linda Crnic Institute for Down Syndrome. They charged the participants to focus on the separate issues of contact registries, research databases, and biobanks through both podium presentations and breakout session discussions. Among the breakout groups for each of the major sessions, participants were asked to generate responses to questions posed by the organizers concerning these three research resources as they related to Down syndrome and then to report back to the group at large with a summary of their discussions. This report represents a synthesis of the discussions and suggested approaches formulated by the group as a whole.

摘要

2010 年 12 月,“唐氏综合征:患者登记处、研究数据库和生物库全国会议”在马里兰州贝塞斯达的美国国立卫生研究院 (NIH) 国立儿童健康与人类发展研究所 (NICHD) 和科罗拉多州丹佛市全球唐氏综合征基金会 (GDSF)/琳达·克里尼克唐氏综合征研究所共同主办。来自各个倡导团体、联邦机构(疾病控制和预防中心以及 NIH 的各个研究所、中心和办公室)、行业成员、临床医生和来自各个学术机构的研究人员的大约 70 名与会者和组织者受到了 NICHD 副主任 Yvonne Maddox 博士和琳达·克里尼克唐氏综合征研究所执行主任 Edward McCabe 博士的欢迎。他们要求与会者通过演讲和分组讨论重点关注单独的联系登记处、研究数据库和生物库问题。在每个主要会议的分组讨论中,要求参与者针对组织者提出的与唐氏综合征相关的这三个研究资源的问题做出回答,然后向全体小组报告他们的讨论摘要。本报告代表了整个小组讨论和提出的方法的综合。

相似文献

1
Down syndrome: national conference on patient registries, research databases, and biobanks.唐氏综合征:患者注册中心、研究数据库和生物库国家会议。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):13-22. doi: 10.1016/j.ymgme.2011.07.005. Epub 2011 Jul 13.
2
Down syndrome: issues to consider in a national registry, research database and biobank.唐氏综合征:国家注册机构、研究数据库和生物库需要考虑的问题。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):10-2. doi: 10.1016/j.ymgme.2011.03.018. Epub 2011 Mar 26.
3
Personalized medicine for individuals with Down syndrome.针对唐氏综合征个体的个性化医疗。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):7-9. doi: 10.1016/j.ymgme.2011.07.008. Epub 2011 Jul 19.
4
Smith-Lemli-Opitz syndrome and inborn errors of cholesterol synthesis: summary of the 2007 SLO/RSH Foundation scientific conference sponsored by the National Institutes of Health.史密斯-莱姆利-奥皮茨综合征与胆固醇合成先天性代谢缺陷:国立卫生研究院主办的2007年史密斯-莱姆利-奥皮茨综合征/罗伯特·史密斯基金会科学会议综述
Genet Med. 2009 May;11(5):359-64. doi: 10.1097/GIM.0b013e31819b246e.
5
Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.尤尼斯·肯尼迪·施莱佛国立儿童健康与人类发展研究所儿科制剂倡议:第二届儿科制剂研讨会会议记录。
Clin Ther. 2012 Nov;34(11):S1-10. doi: 10.1016/j.clinthera.2012.09.013.
6
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia.新冠病毒疾病网络:一家意大利参考机构对新型大流行病研究挑战的应对措施
Clin Microbiol Infect. 2020 Nov;26(11):1576-1578. doi: 10.1016/j.cmi.2020.06.028. Epub 2020 Jun 30.
7
A national network to advance the field of cancer and female sexuality.一个推进癌症与女性性行为领域的国家网络。
J Sex Med. 2013 Feb;10(2):319-25. doi: 10.1111/jsm.12061.
8
Financial stability in biobanking: unique challenges for disease-focused foundations and patient advocacy organizations.生物样本库中的财务稳定性:针对疾病的基金会和患者权益倡导组织面临的独特挑战。
Biopreserv Biobank. 2014 Oct;12(5):294-9. doi: 10.1089/bio.2014.0053. Epub 2014 Oct 14.
9
Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB).创建一个与罕见病生物库数据库链接的全球罕见病患者登记处:罕见病-HUB(RD-HUB)。
Contemp Clin Trials. 2010 Sep;31(5):394-404. doi: 10.1016/j.cct.2010.06.007. Epub 2010 Jul 8.
10
Association of National Institute of Child Health and Human Development Career Development Awards With Subsequent Research Project Grant Funding.国家儿童健康与人类发展研究所职业发展奖与后续研究项目资助的关联。
JAMA Pediatr. 2018 Mar 1;172(3):226-231. doi: 10.1001/jamapediatrics.2017.4305.

引用本文的文献

1
Expression profile of inflammasome genes in individuals with Down syndrome.唐氏综合症个体中炎性小体基因的表达谱
Genet Mol Biol. 2024 Sep 9;47(4):e20230339. doi: 10.1590/1678-4685-GMB-2023-0339. eCollection 2024.
2
Establishment of a Biorepository for Down Syndrome: Experience of the Inter-Institutional Multidisciplinary BioBank - BioBIM.建立唐氏综合征生物库:多机构多学科生物银行-BioBIM 的经验。
Discov Med. 2024 May;36(184):913-922. doi: 10.24976/Discov.Med.202436184.85.
3
The National Institutes of Health INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project: Accelerating research discoveries for people with Down syndrome across the lifespan.美国国立卫生研究院全生命周期共病状况调查以了解唐氏综合征(INCLUDE)项目:加速针对唐氏综合征患者全生命周期的研究发现。
Am J Med Genet C Semin Med Genet. 2024 Mar;196(1):e32081. doi: 10.1002/ajmg.c.32081. Epub 2024 Jan 10.
4
Trisomy 21 and Assisted Reproductive Technologies: A review.三体 21 与辅助生殖技术:综述。
JBRA Assist Reprod. 2022 Jan 17;26(1):129-141. doi: 10.5935/1518-0557.20210047.
5
Auditory-Perceptual Features of Speech in Children and Adults With Down Syndrome: A Speech Profile Analysis.唐氏综合征儿童和成人的言语听觉感知特征:言语特征分析。
J Speech Lang Hear Res. 2021 Apr 14;64(4):1157-1175. doi: 10.1044/2021_JSLHR-20-00617. Epub 2021 Mar 31.
6
Comparative genome-wide DNA methylation analysis in myocardial tissue from donors with and without Down syndrome.唐氏综合征供体与非唐氏综合征供体心肌组织的全基因组 DNA 甲基化比较分析。
Gene. 2021 Jan 5;764:145099. doi: 10.1016/j.gene.2020.145099. Epub 2020 Aug 27.
7
Intellectual and developmental disabilities research centers: Fifty years of scientific accomplishments.智力和发育障碍研究中心:五十年的科学成就。
Ann Neurol. 2019 Sep;86(3):332-343. doi: 10.1002/ana.25531. Epub 2019 Jul 27.
8
Augmentative and alternative communication in children with Down's syndrome: a systematic review.唐氏综合征儿童的辅助沟通:系统综述。
BMC Pediatr. 2018 May 11;18(1):160. doi: 10.1186/s12887-018-1144-5.
9
High percentages of embryos with 21, 18 or 13 trisomy are related to advanced paternal age in donor egg cycles.在供卵周期中,21、18或13三体胚胎的高比例与父亲高龄有关。
JBRA Assist Reprod. 2018 Mar 1;22(1):26-34. doi: 10.5935/1518-0557.20180004.
10
Pharmacotherapeutic Considerations for Individuals with Down Syndrome.唐氏综合征患者的药物治疗考量
Pharmacotherapy. 2017 Feb;37(2):214-220. doi: 10.1002/phar.1880. Epub 2017 Jan 13.

本文引用的文献

1
Genetic Alliance Registry and BioBank: a novel disease advocacy-driven research solution.遗传联盟注册库与生物样本库:一种由疾病倡导驱动的新型研究解决方案。
Per Med. 2011 Mar;8(2):207-213. doi: 10.2217/pme.11.1.
2
Down syndrome: issues to consider in a national registry, research database and biobank.唐氏综合征:国家注册机构、研究数据库和生物库需要考虑的问题。
Mol Genet Metab. 2011 Sep-Oct;104(1-2):10-2. doi: 10.1016/j.ymgme.2011.03.018. Epub 2011 Mar 26.
3
Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006.2004 - 2006年美国部分出生缺陷的最新全国出生患病率估计
Birth Defects Res A Clin Mol Teratol. 2010 Dec;88(12):1008-16. doi: 10.1002/bdra.20735. Epub 2010 Sep 28.
4
The case for a global rare-diseases registry.建立全球罕见病登记处的理由。
Lancet. 2011 Mar 26;377(9771):1057-9. doi: 10.1016/S0140-6736(10)60680-0. Epub 2010 Jul 30.
5
Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB).创建一个与罕见病生物库数据库链接的全球罕见病患者登记处:罕见病-HUB(RD-HUB)。
Contemp Clin Trials. 2010 Sep;31(5):394-404. doi: 10.1016/j.cct.2010.06.007. Epub 2010 Jul 8.
6
Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics.对唐氏综合征儿童进行自闭症谱系障碍筛查:人群患病率和筛查测试特征。
J Dev Behav Pediatr. 2010 Apr;31(3):181-91. doi: 10.1097/DBP.0b013e3181d5aa6d.
7
Setting a public health research agenda for Down syndrome: summary of a meeting sponsored by the Centers for Disease Control and Prevention and the National Down Syndrome Society.制定唐氏综合征公共卫生研究议程:疾病控制与预防中心及全国唐氏综合征协会主办会议总结
Am J Med Genet A. 2008 Dec 1;146A(23):2998-3010. doi: 10.1002/ajmg.a.32581.
8
Registration of Down syndrome in the Medical Birth Registry of Norway: validity and time trends.挪威医学出生登记处中唐氏综合征的登记:有效性和时间趋势。
Acta Obstet Gynecol Scand. 2008;87(8):824-30. doi: 10.1080/00016340802217184.
9
Causes of death and case fatality rates among infants with down syndrome in metropolitan Atlanta.大亚特兰大地区唐氏综合征婴儿的死因及病死率
Birth Defects Res A Clin Mol Teratol. 2007 Nov;79(11):775-80. doi: 10.1002/bdra.20414.
10
The four ages of Down syndrome.唐氏综合征的四个阶段。
Eur J Public Health. 2007 Apr;17(2):221-5. doi: 10.1093/eurpub/ckl103. Epub 2006 Jul 19.